UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
May 5, 2025
Accession Number:
0001213900-25-038970
Submission Type:
POS AM
CIK:
0001894525
Company Name:
Apimeds Pharmaceuticals US, Inc.
File Number:
333-282324